China's Fosun said to mull sale of India’s $3.6 billion Gland Pharma

A sale would help Gland’s Chinese owner raise cash as the once-acquisitive group seeks to shore up its balance sheet. Fosun International has been exploring options for a number of assets, including French resort operator Club Med and some domestic food and beverage operations, Bloomberg News has reported.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ZVnj2bJ
via IFTTT